NASDAQ
Indaptus Therapeutics, Inc. (INDP) has a current ratio of 1.51x as of Monday, May 25, 2026. This represents a 74.49% decrease compared to its 12-month average of 5.93x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.